Medley Therapeutics, Inc.
PrivateLast Round
Series B
Jan 12, 2022
Total Funding Raised
$30.6M
Company Overview
Medley Therapeutics, Inc. is a biotechnology company that develops regenerative genetic medicines and advanced biologics to treat severe diseases such as heart failure, fibrotic diseases, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medley Therapeutics, Inc. Comparables
Compare Medley Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vivace Therapeutics | 86% | |
| Renova Therapeutics | 84% | |
| Tenaya Therapeutics | 81% |
Medley Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 12, 2022 | ||||
| Seed | Mar 1, 2021 |
Medley Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fjord Ventures | Series B |
| ArrowMark Partners | Series B |
| Alexandria Venture Investments | Seed |
| BCM Ventures | Series B |
| Alexandria Venture Investments | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 12, 2022
$30M round with participation from ArrowMark Partners and Fjord Ventures.
Medley Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Medley Therapeutics, Inc.'s valuation, stock price, and market status.
Is YAPtx a public or private company?
YAPtx is a private company.
What is the current stock price of YAPtx?
YAPtx is a private company with no public stock price. No recent secondary market data is available.
How much is YAPtx worth (valuation)?
Valuation information for YAPtx is not publicly available.
Can I buy YAPtx stock?
YAPtx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was YAPtx's last funding round?
YAPtx's most recent funding round was Series B on January 12, 2022.
Who are the main investors in YAPtx?
Key investors in YAPtx include Fjord Ventures, ArrowMark Partners, Alexandria Venture Investments, BCM Ventures, Alexandria Venture Investments.
Will YAPtx IPO soon?
No public IPO plans have been announced for YAPtx.
How can I track YAPtx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor YAPtx's secondary market activity and sign up for updates.